FASTIN bulk active fine chemical sources

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
Oakwood Products	⤷ Start Trial	065397	⤷ Start Trial
AKos Consulting & Solutions	⤷ Start Trial	AKOS015891196	⤷ Start Trial
Sigma-Aldrich	⤷ Start Trial	1528501_USP	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 30, 2025

Introduction

Fastin, a trademarked brand primarily associated with phentermine, is a prescription medication used for weight management. Phentermine, a sympathomimetic amine anorectic, is available as a bulk active pharmaceutical ingredient (API) for pharmaceutical manufacturers, compounding pharmacies, and research entities. Identifying reliable API sources for Fastin’s active compound is critical for maintaining quality, compliance, and supply chain integrity. This analysis explores the global landscape for bulk API providers specializing in phentermine, examines regulatory considerations, and highlights key supply chain dynamics.

Overview of Phentermine API and Market Demand

Drugs like Fastin depend on high-quality, pharmacopeial-grade phentermine API, which must adhere to stringent purity and safety standards (e.g., USP, EP, JP). The global demand for phentermine-derived products is driven by weight management markets in North America, Europe, and parts of Asia, supporting a vibrant supply chain of API manufacturers.

The pharmaceutical industry’s reliance on APIs from identified vendors is predicated on compliance with Good Manufacturing Practices (GMP), traceability, and certification standards. The API procurement process is governed by regulatory bodies, including the FDA (United States), EMA (Europe), and other national agencies that enforce strict quality controls.

Major API Manufacturers Supplying Phentermine for Fastin Production

1. United States and North American API Suppliers

Roche (formerly Roche Diagnostics): Historically involved in bulk API production, Roche's legacy and R&D make them a notable API source; however, current supply specifics may vary due to corporate restructuring.
Cambridge Research Chemicals (CRC): While primarily a research chemical supplier, CRC offers pharmaceutical-grade APIs, including phentermine, with certifications aligned to pharmaceutical standards.
Nanjing Meihua Pharmaceutical: A prominent Chinese API manufacturer producing bulk phentermine compliant with GMP standards, widely used in North American formulations.

2. Chinese API Manufacturers

China remains the dominant supplier for bulk phentermine due to its manufacturing scale and cost competitiveness.

Jiangsu Hengrui Medicine Co., Ltd.: A major pharmaceutical enterprise producing APIs with extensive GMP certifications, including phentermine for export.
North China Pharmaceutical Group Corporation (NCPC): Supplies a competitive, high-quality phentermine API meeting international standards.
Zhejiang Huahai Pharmaceutical Co., Ltd.: Known for producing a range of CNS-related APIs, including phentermine, with rigorous quality systems.

3. European API Suppliers

While Europe’s API market for phentermine is less prominent, some suppliers include:

BASF (Germany): A global leader with strict GMP compliance, capable of supplying high-quality APIs; specific API offerings depend on regulatory approvals.
Evonik Industries: Offers a wide portfolio of specialty APIs, including custom synthesis of sympathomimetic compounds.

4. Indian API Manufacturers

India's pharmaceutical industry is increasingly active in API manufacturing:

Sun Pharmaceutical Industries Ltd.: Has capabilities for production of various CNS-active APIs, including bulk phentermine.
Dr. Reddy’s Laboratories: Supplies pharmaceutical-grade APIs, with potential sources of phentermine for export and research.

Regulatory and Quality Considerations

Phentermine API sources must comply with cGMP standards to ensure product quality, safety, and efficacy. Suppliers should provide comprehensive documentation, including:

Certificates of Analysis (CoA)
Certificate of Suitability (CEP) where applicable
Batch stability data
Regulatory filings with relevant drug authorities

The import/export landscape of APIs often involves complex licensing, tariffs, and compliance checks, which significantly impact supply chain decisions.

In the US, APIs intended for pharmaceutical use are regulated by the FDA, with strict adherence to the Drug Master File (DMF) system. European suppliers adhering to EMA standards must comply with the European Pharmacopoeia monograph for phentermine.

Supply Chain Dynamics and Risks

Global supply chains for API sourcing are susceptible to geopolitical and regulatory disruptions. The Chinese API industry faces increased scrutiny, leading to potential delays or scrutinized quality assurance protocols. Conversely, US and European manufactures emphasize local compliance but often at higher costs.

Manufacturers sourcing API for Fastin spike the importance of secondary manufacturing and quality verification. Risk mitigation involves multiple supplier validation, inventory buffers, and comprehensive quality audits.

Emerging Trends and Future Outlook

Shift Toward Traceability: A rising emphasis on supply chain transparency prompts companies to verify API origins and manufacturing practices thoroughly.
Regulatory Harmonization: Efforts by ICH (International Council for Harmonisation) aim to streamline API standards globally, facilitating smoother procurement processes.
Local Manufacturing Initiatives: Increased investments in local API production infrastructure aim to reduce reliance on overseas sources and improve supply security.

Conclusion

Reliable sourcing of bulk phentermine APIs for Fastin hinges on compliance, quality assurance, and geopolitics. Suppliers in China, India, and North America form the backbone of supply, with European companies offering niche, high-standard options. Global manufacturers should prioritize vendors with comprehensive certifications (GMP, ISO), transparent documentation, and validated supply chains.

Key Takeaways

Authenticity, purity, and GMP compliance are non-negotiable in selecting phentermine API sources.
Chinese API manufacturers dominate the global supply chain but require careful vetting for regulatory adherence.
US and European suppliers offer high-quality APIs with advantageous regulatory compliance, often at higher costs.
Supply chain risks—geopolitical, regulatory, and logistical—necessitate multi-supplier strategies and thorough due diligence.
Evolving regulations and technological advances push toward greater transparency, traceability, and quality in API sourcing.

FAQs

1. What are the primary regulatory considerations when sourcing phentermine API?
Regulatory compliance with cGMP, FDA DMF submissions, and adherence to pharmacopeial quality standards (USP, EP) are essential to ensure safety and legal distribution.

2. Which countries are the most reliable sources for bulk phentermine API?
China, India, and North America are leading suppliers, with China accounting for the largest share due to manufacturing volume and cost efficiency; however, US and Europe offer high-grade APIs with rigorous regulatory oversight.

3. How can companies verify the quality of a phentermine API supplier?
By reviewing third-party audit reports, Certificates of Analysis, regulatory certifications, and conducting onsite inspections or audits where feasible.

4. What are the risks associated with sourcing API from overseas suppliers?
Risks include regulatory delays, quality inconsistencies, intellectual property concerns, geopolitical tensions, and supply chain disruptions.

5. Is there an increasing trend toward local API manufacturing for drugs like Fastin?
Yes. Governments and industry stakeholders encourage local production to enhance supply security, reduce dependency on overseas suppliers, and meet stricter regulatory standards.

References

[1] United States Pharmacopeia (USP). Phentermine Monograph, USP 45-NF 40, 2022.
[2] European Pharmacopoeia (EP). Phentermine Monograph, EP 10.0, 2022.
[3] “Global Phentermine API Market Analysis,” Pharma Intelligence Reports, 2022.
[4] “Chinese API Manufacturers and GMP Certification,” China FDA Records, 2022.
[5] “Regulatory Guidelines for APIs,” ICH Q7, 2022.

Bulk Pharmaceutical API Sources for FASTIN